Status:

COMPLETED

A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions:

Kidney Failure, Chronic

Anemia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study in early hemodialysis patients (on dialysis 3 to 18 months) is to assess the effect of correction versus partial correction of anemia using epoetin alfa on heart pumping func...

Detailed Description

Cardiovascular disease is very common among patients with end-stage renal disease. This study is a long-term, double-blind, parallel-group, multicenter study to determine the efficacy and safety of ad...

Eligibility Criteria

Inclusion

  • On hemodialysis for 3 to 18 months and expected to remain on hemodialysis for at least two more years and with a life expectancy of a year or more
  • Kidney transplant patients, whose transplant has failed, and now have been on hemodialysis for 3-18 months, may be eligible for the study, if they are not receiving excessive immunosuppression (e.g., \<=10 mg of steroids/day allowed)
  • Pre-dialysis hemoglobin 8-12 g/dL, inclusive, within the previous month (single reading is sufficient)
  • Stable hemodialysis vascular access, within the previous 3 months
  • No heart disease or asymptomatic heart disease without enlarged heart

Exclusion

  • Heart diseases for which surgical intervention occurred during the previous two years or which may require intervention within the next year
  • Patients with medical conditions likely to affect the response to epoetin
  • Predialysis sitting diastolic blood pressure \>= 100 mmHg on average for the previous month
  • Folate, Vitamin B12, or transferrin deficiency
  • History of seizure within 1 year
  • Transfusion within 30 days prior to study entry.

Key Trial Info

Start Date :

February 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2003

Estimated Enrollment :

596 Patients enrolled

Trial Details

Trial ID

NCT00261521

Start Date

February 1 2000

End Date

May 1 2003

Last Update

December 3 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.